Response to the BRAF/MEK inhibitors dabrafenib/trametinib in an adolescent with a BRAF V600E mutated anaplastic ganglioglioma intolerant to vemurafenib

被引:34
作者
Marks, Asher M. [1 ]
Bindra, Ranjit S. [2 ]
DiLuna, Michael L. [3 ]
Huttner, Anita [4 ]
Jairam, Vikram [2 ]
Kahle, Kristopher T. [3 ]
Kieran, Mark W. [5 ]
机构
[1] Yale Univ, Sch Med, Dept Pediat Hematol Oncol, 333 Cedar St,LMP 2073, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Radiat Oncol, New Haven, CT USA
[3] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT USA
[4] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA
[5] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA
关键词
AYA; BRAF inhibitor; BRAF V600E; CNS tumor; ganglioglioma; MEK inhibitor; STEM GANGLIOGLIOMA; DABRAFENIB; MELANOMA;
D O I
10.1002/pbc.26969
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Efficacy of BRAF V600E targeted therapies in brain tumors harboring the mutation has been shown in several case reports and is currently being studied in larger clinical trials. Monotherapy with vemurafenib has been associated with significant side effects, including rashes, papillomas, and squamous cell carcinomas. Here we describe an adolescent female with anaplastic ganglioglioma and significant skin reaction to vemurafenib with subsequent tumor response and tolerance to the BRAF/MEK inhibitor combination of dabrafenib and trametinib without recurrence of previous reaction.
引用
收藏
页数:4
相关论文
共 17 条
[1]   Successful Retreatment of a Child with a Refractory Brainstem Ganglioglioma with Vemurafenib [J].
Aguilera, Dolly ;
Janss, Anna ;
Mazewski, Claire ;
Castellino, Robert Craig ;
Schniederjan, Matthew ;
Hayes, Laura ;
Brahma, Barunashish ;
Fogelgren, Lauren ;
MacDonald, Tobey J. .
PEDIATRIC BLOOD & CANCER, 2016, 63 (03) :541-543
[2]   Vemurafenib in Pediatric Patients With BRAFV600E Mutated High-Grade Gliomas [J].
Bautista, Francisco ;
Paci, Angelo ;
Minard-Colin, Veronique ;
Dufour, Christelle ;
Grill, Jacques ;
Lacroix, Ludovic ;
Varlet, Pascale ;
Valteau-Couanet, Dominique ;
Geoerger, Birgit .
PEDIATRIC BLOOD & CANCER, 2014, 61 (06) :1101-1103
[3]  
Blümcke I, 2002, J NEUROPATH EXP NEUR, V61, P575
[4]   Vemurafenib and Radiosensitization [J].
Boussemart, Lise ;
Boivin, Catherine ;
Claveau, Joel ;
Tao, Yun Gan ;
Tomasic, Gorana ;
Routier, Emilie ;
Mateus, Christine ;
Deutsch, Eric ;
Robert, Caroline .
JAMA DERMATOLOGY, 2013, 149 (07) :855-857
[5]   BRAFV600E mutation is a negative prognosticator in pediatric ganglioglioma [J].
Dahiya, Sonika ;
Haydon, Devon H. ;
Alvarado, David ;
Gurnett, Christina A. ;
Gutmann, David H. ;
Leonard, Jeffrey R. .
ACTA NEUROPATHOLOGICA, 2013, 125 (06) :901-910
[6]   Molecular Pathways: Response and Resistance to BRAF and MEK Inhibitors in BRAFV600E Tumors [J].
Das Thakur, Meghna ;
Stuart, Darrin D. .
CLINICAL CANCER RESEARCH, 2014, 20 (05) :1074-1080
[7]   Cooperative interactions of BRAFV600E kinase and CDKN2A locus deficiency in pediatric malignant astrocytoma as a basis for rational therapy [J].
Huillard, Emmanuelle ;
Hashizume, Rintaro ;
Phillips, Joanna J. ;
Griveau, Amelie ;
Ihrie, Rebecca A. ;
Aoki, Yasuyuki ;
Nicolaides, Theodore ;
Perry, Arie ;
Waldman, Todd ;
McMahon, Martin ;
Weiss, William A. ;
Petritsch, Claudia ;
James, C. David ;
Rowitch, David H. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (22) :8710-8715
[8]   Successful switch to dabrafenib after vemurafenib-induced toxic epidermal necrolysis [J].
Jeudy, G. ;
Dalac-Rat, S. ;
Bonniaud, B. ;
Hervieu, A. ;
Petrella, T. ;
Collet, E. ;
Vabres, P. .
BRITISH JOURNAL OF DERMATOLOGY, 2015, 172 (05) :1454-1455
[9]   CENTRAL-NERVOUS-SYSTEM GANGLIOGLIOMAS .2. CLINICAL OUTCOME [J].
LANG, FF ;
EPSTEIN, FJ ;
RANSOHOFF, J ;
ALLEN, JC ;
WISOFF, J ;
ABBOTT, IR ;
MILLER, DC .
JOURNAL OF NEUROSURGERY, 1993, 79 (06) :867-873
[10]   Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma [J].
Long, G. V. ;
Stroyakovskiy, D. ;
Gogas, H. ;
Levchenko, E. ;
de Braud, F. ;
Larkin, J. ;
Garbe, C. ;
Jouary, T. ;
Hauschild, A. ;
Grob, J. J. ;
Sileni, V. Chiarion ;
Lebbe, C. ;
Mandala, M. ;
Millward, M. ;
Arance, A. ;
Bondarenko, I. ;
Haanen, J. B. A. G. ;
Hansson, J. ;
Utikal, J. ;
Ferraresi, V. ;
Kovalenko, N. ;
Mohr, P. ;
Probachai, V. ;
Schadendorf, D. ;
Nathan, P. ;
Robert, C. ;
Ribas, A. ;
DeMarini, D. J. ;
Irani, J. G. ;
Casey, M. ;
Ouellet, D. ;
Martin, A. -M. ;
Le, N. ;
Patel, K. ;
Flaherty, K. .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (20) :1877-1888